Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Yaron D. Barac, M.D, Ph.D Associate Professor of Surgery and Cardiovascular Physiology; Director of the Heart and Lung Transplantation and Mechanical Circulatory Support Programs; Director of The Cardiothoracic Surgery Translational Research Lab. The Division of Cardiovascular and Thoracic Surgery, Rabin Medical Center, Tel Aviv University, Israel. Scott C. Silvestry, M.D Co-Executive Medical Director, Heart, Lung, and Vascular Institute. Surgical Director, Thoracic Transplant Programs. AdventHealth Transplant Institute, AdventHealth Orlando. Mani A. Daneshmand, M.D Andrew J. McKelvey Professor of Lung Transplant Surgery. Director, Section of Thoracic Transplant and MCS Surgery. Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine. Daniel J. Goldstein, M.D Professor and Vice-Chair, Surgical Director, Cardiac Transplantation & Mechanical Assistance Programs, Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine.
Inhaltsangabe
Section IX The MCS Patient 785 Stephan Schueler
56 Postoperative ICU Care for Mechanical Circulatory Support Patients 787 Nicholas C. Cavarocchi
57 Post-ICU LVAD Course 797 Melissa Lyle and Divya Gupta
58 The VAD Coordinator's Role: Education and Team Communication 805 Heidi Craddock and Christy Kay
59 The LVAD Patient Bridging to Wellness: Psychological Assessment and Rehabilitation 812 Mary Amanda Dew
60 LVAD Clinic: Outpatient Monitoring and Causes for Readmission 833 Nancy K. Sweitzer and Sophia Airhart
61 Hemodynamic Optimization of the LVAD Patient 849 Nikhil Narang, Gabriel Sayer, and Nir Uriel
62 Myocardial Recovery During LVAD Support 858 Christos P. Kyriakopoulos, Craig H. Selzman, and Stavros G. Drakos
Section X MCS-Related Complications in the Chronic Patient 881 Joseph G. Rogers
63 Right Heart Failure: Risk Scores and Management 883 Brent C. Lampert and Jeffrey J. Teuteberg
64 LVAD-Associated Acquired von Willebrand Syndrome and Gastrointestinal Bleeding: Pathophysiology, Etiologies, and Management 898 Sanjhai L. Ramdeen and Carlo R. Bartoli
65 Mechanical Circulatory Support Infections 907 Gerard Giblin, Ciara O'Connor, Emer Joyce, and Margaret M. Hannan
66 Pump Thrombosis: Medical and Surgical Management 932 Andrew Xanthopoulos, Filippos Triposkiadis, and Randall C. Starling
67 Neurologic Complications: Pathophysiology, Incidence, Types, Prevention, and Management 945 Paolo C. Colombo, Chinwe Ibeh, Kara R. Melmed, and Joshua Willey
68 Renal Dysfunction in MCS Patients: Perioperative and Long-Term Considerations 966 Natasha A. Vedage and Meredith A. Brisco-Bacik
69 De Novo Aortic Insufficiency 977 Jennifer Cowger
Section XI The LVAD Program and Future Directions 987 Daniel J. Goldstein
70 Regulatory and Miscellaneous Aspects of an LVAD Program 989 Christina Cheyne, Igor Gosev, and Sunil Prasad
71 Current Limitations and Characteristics of Next-Generation Ventricular Assist Devices 996 Yuji Kaku, Yoshifumi Naka, and Daniel Burkhoff
72 MCS and Novel Adjunctive Therapies: An Update 1011 Doris A. Taylor, Lourdes I. Chacon, Camila Hochman-Mendez, and Luiz C. Sampaio
73 Artificial Intelligence and Machine Learning in MCS 1021 Manreet Kanwar, Marek J. Druzdzel, Faezeh Movahedi, and Jim Antaki
Lung Transplant
Section XII The Pretransplant Phase: Recipient 1035 Mani A. Daneshmand
74 Recipient Selection and the Lung Transplant Window for Adult and Pediatric Patients 1037 David C. Neujahr and William R. Hunt
75 Advanced Lung Disease 1053 Cynthia Jane Gries
76 The Acute Lung Failure Patient and Temporary Mechanical Support 1070 Purav Shah, Maria C. Creel, and Satish Chandrashekaran
77 Preoperative Optimization for Lung Transplant 1081 Andrew M. Vekstein, John C. Haney, John M. Reynolds, and Jacob A.Klapper
78 Lung Transplant Waitlist Management 1089 Joshua B. Smith and Alice L. Gray
Section XIII The Pretransplant Phase: Donor 1101 Yaron D. Barac
79 Prioritization: Candidate Selection and Organ Allocation Systems 1103 Are Martin Holm andMatthew G. Hartwig
80 Donor Lungs Evaluation 1110 Louis Stein, Alex Leung, Yaron D. Barac, Mani A. Daneshmand, and Yuri Pesachovitz
81 Lung Transplantation: Marginal Donors and Risk Assessment 1119 Laura L. Donahoe and Shaf Keshavjee
82 Organ Procurement and Preservation 1132 Reshma Biniwale and Abbas Ardehal
83 Machines and Donation After Circulatory Death (DCD) in Lung Transplantation 1145 Gabriel Loor and Pablo Sanchez
56 Postoperative ICU Care for Mechanical Circulatory Support Patients 787 Nicholas C. Cavarocchi
57 Post-ICU LVAD Course 797 Melissa Lyle and Divya Gupta
58 The VAD Coordinator's Role: Education and Team Communication 805 Heidi Craddock and Christy Kay
59 The LVAD Patient Bridging to Wellness: Psychological Assessment and Rehabilitation 812 Mary Amanda Dew
60 LVAD Clinic: Outpatient Monitoring and Causes for Readmission 833 Nancy K. Sweitzer and Sophia Airhart
61 Hemodynamic Optimization of the LVAD Patient 849 Nikhil Narang, Gabriel Sayer, and Nir Uriel
62 Myocardial Recovery During LVAD Support 858 Christos P. Kyriakopoulos, Craig H. Selzman, and Stavros G. Drakos
Section X MCS-Related Complications in the Chronic Patient 881 Joseph G. Rogers
63 Right Heart Failure: Risk Scores and Management 883 Brent C. Lampert and Jeffrey J. Teuteberg
64 LVAD-Associated Acquired von Willebrand Syndrome and Gastrointestinal Bleeding: Pathophysiology, Etiologies, and Management 898 Sanjhai L. Ramdeen and Carlo R. Bartoli
65 Mechanical Circulatory Support Infections 907 Gerard Giblin, Ciara O'Connor, Emer Joyce, and Margaret M. Hannan
66 Pump Thrombosis: Medical and Surgical Management 932 Andrew Xanthopoulos, Filippos Triposkiadis, and Randall C. Starling
67 Neurologic Complications: Pathophysiology, Incidence, Types, Prevention, and Management 945 Paolo C. Colombo, Chinwe Ibeh, Kara R. Melmed, and Joshua Willey
68 Renal Dysfunction in MCS Patients: Perioperative and Long-Term Considerations 966 Natasha A. Vedage and Meredith A. Brisco-Bacik
69 De Novo Aortic Insufficiency 977 Jennifer Cowger
Section XI The LVAD Program and Future Directions 987 Daniel J. Goldstein
70 Regulatory and Miscellaneous Aspects of an LVAD Program 989 Christina Cheyne, Igor Gosev, and Sunil Prasad
71 Current Limitations and Characteristics of Next-Generation Ventricular Assist Devices 996 Yuji Kaku, Yoshifumi Naka, and Daniel Burkhoff
72 MCS and Novel Adjunctive Therapies: An Update 1011 Doris A. Taylor, Lourdes I. Chacon, Camila Hochman-Mendez, and Luiz C. Sampaio
73 Artificial Intelligence and Machine Learning in MCS 1021 Manreet Kanwar, Marek J. Druzdzel, Faezeh Movahedi, and Jim Antaki
Lung Transplant
Section XII The Pretransplant Phase: Recipient 1035 Mani A. Daneshmand
74 Recipient Selection and the Lung Transplant Window for Adult and Pediatric Patients 1037 David C. Neujahr and William R. Hunt
75 Advanced Lung Disease 1053 Cynthia Jane Gries
76 The Acute Lung Failure Patient and Temporary Mechanical Support 1070 Purav Shah, Maria C. Creel, and Satish Chandrashekaran
77 Preoperative Optimization for Lung Transplant 1081 Andrew M. Vekstein, John C. Haney, John M. Reynolds, and Jacob A.Klapper
78 Lung Transplant Waitlist Management 1089 Joshua B. Smith and Alice L. Gray
Section XIII The Pretransplant Phase: Donor 1101 Yaron D. Barac
79 Prioritization: Candidate Selection and Organ Allocation Systems 1103 Are Martin Holm andMatthew G. Hartwig
80 Donor Lungs Evaluation 1110 Louis Stein, Alex Leung, Yaron D. Barac, Mani A. Daneshmand, and Yuri Pesachovitz
81 Lung Transplantation: Marginal Donors and Risk Assessment 1119 Laura L. Donahoe and Shaf Keshavjee
82 Organ Procurement and Preservation 1132 Reshma Biniwale and Abbas Ardehal
83 Machines and Donation After Circulatory Death (DCD) in Lung Transplantation 1145 Gabriel Loor and Pablo Sanchez
Section XIV The Transplant Phase 1163 M
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
